Individualized assessment of bleeding versus thrombosis risk is required for managing antithrombotic therapy during invasive procedures.
May inform periprocedural antithrombotic decisions; leaves open validation of risk tools in trials.
When patients receiving anticoagulation therapy undergo invasive procedures, management requires an individualized assessment of the risk of bleeding versus the risk of thrombosis. This review explains management, including bridging anticoagulation for patients receiving warfarin.
No takes yet. Share an insight, caveat, or question.
Baron et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: